Navigation Links
InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL
Date:2/20/2008

HATBORO, Pa., Feb. 20 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that David Gulian, President and CEO, will present at the Growth & Value Investor Conference to be held at the Westin Fort Lauderdale in Florida on February 27-28, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO )

Mr. Gulian is scheduled to present on Thursday, February 28th followed by a question and answer session. The Growth & Value Investor Conference will be held at the Westin Fort Lauderdale, located at 400 Corporate Drive, Fort Lauderdale, FL. The slide presentation discussed at the conference will be available on InfoLogix's website located at http://www.infologix.com. Electronic versions of the presentation can also be received via email, fax or postal service by contacting InfoLogix's Investor Relations department at the address provided at the end of this release.

InfoLogix's enterprise mobility solutions have been selected by more than 1,400 hospitals and 800 commercial organizations, including 47 of the Fortune 500, to improve productivity, efficiency and revenues. Most recently, InfoLogix has been spotlighted in a FOX Business News feature on medication management and attracted former executives from SAP Americas and GE Healthcare to its team.

About InfoLogix, Inc.

InfoLogix is a leading provider of technology and RFID based intelligence solutions that enable the mobile enterprise. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes for the healthcare industry and the commercial marketplace. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, Adventist Health, Swedish Medical Center, and Stanford School of Medicine. Founded in 2001 and headquartered in suburban Philadelphia, PA, InfoLogix has been named the sixth fastest growing new business in the United States for the last three years by Entrepreneur Magazine. InfoLogix is a publicly-traded company (Nasdaq: IFLG). For more information, visit http://www.infologix.com.

About the Growth & Value Investor Conference

The Growth & Value Investor Conference has carefully designated upwards of 30 outstanding publicly traded companies (NYSE, NASDAQ, AMEX, Canadian listed companies and more) and offers you a live, inside look into the core of their strategies, strength of management and the potential for profit. Each corporate presentation is planned to be followed by a question and answer session and one-on-one meeting opportunities are available. There is nothing to buy at the Growth & Value Investor Conference. All are welcome. Attendance is free.

The Growth & Value Investor Conference, "Spring Break for Wall Street," will be held on Wednesday and Thursday, February 27 & 28, 2008. The Complimentary Cocktail Reception will be held from 4:00 PM - 5:00 PM and the Corporate Presentations will follow from 5:00 PM - 9:00 PM. The Growth & Value Investor Conference is presented by LDV Capital Management, a Registered Investment Advisory Firm Licensed with the State of Florida.


'/>"/>
SOURCE InfoLogix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... ... its executive team as the President of its HealthBI division. McFarland will ... and contact centers. , “Scott is a utility player who balances his ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced a ... When we’re born, Nature gives us a full supply of melanin – in the ... lose this natural glare-reducing pigment; however, around the age of thirty, we develop a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... the present, Mirixa Corporation recently unveiled the MirixaPro 6.0 platform. As the ... how medication management services are delivered. Based on industry research and market ...
(Date:9/19/2017)... ... September 19, 2017 , ... Back Pain Centers of ... back pain with a reputable physician in their area, announces the addition of ... as Nevada Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. ...
(Date:9/19/2017)... ... 2017 , ... The ISO 9001 standard sets out the requirements for a ... and improve customer satisfaction. ISO 9001:2015 was released in 2015 and certified organizations have ... September 2018. , As described in this white paper , ISO ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
Breaking Medicine Technology: